Kamal D. Puri

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman et al. · Blood · 2010 · 712 citations · Full text

Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease

James Kinchen, Hannah H. Chen, Kaushal Parikh et al. · Cell · 2018 · 681 citations · Full text

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E.M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

The Kinetics of L-selectin Tethers and the Mechanics of Selectin-mediated Rolling

R. Alon, Shuqi Chen, Kamal D. Puri et al. · The Journal of Cell Biology · 1997 · 352 citations · Full text

Platelet-Mediated Lymphocyte Delivery to High Endothelial Venules

Thomas G. Diacovo, Kamal D. Puri, R A Warnock et al. · Science · 1996 · 304 citations

Immunology, Blood Cell, Biomedical Engineering +18